Paradox of the ‘patient’ paragon

IIPM PUBLICATION
Just for records, Ranbaxy is consistently ranked among the world’s top ten global generic companies. Well, like we said, that was just for records. What you might not know is that this company’s net profits grew by a behemothic 70% in the quarter ending June 2006, and by a ponderous 20% when compared to the previous quarter. Coming back to records, having its headquarters in India, the company has revenues to the tune of $1.1 billion, thanks to its presence in some 125 countries. Established in the year 1961, over 76% of Ranbaxy’s revenues today come from its overseas operations, with the US market contributing a mammoth 28%. Ranbaxy is one of the first Indian generic companies, which has diversified into NDDR (new drug discovery research) and NCE (new chemical entities).

For Complete IIPM Article, Click on IIPM Article

Source : IIPM Editorial, 2006, Arindam Chaudhuri's Initiative

For More IIPM Article, Visit Below....
IIPM Links
IIPM Students Life > Campus Placement
IIPM Academics > Faculty
IIPM Academics : Curriculum
IIPM Alliances
ABOUT IIPM
IIPM RANKED AHEAD OF FIVE OF THE IIMS RATED AS ONE ...
More about IIPM Fair game?